DOC vs NLY
Healthpeak Properties vs Annaly Capital Management — AI-powered side-by-side comparison
DOC
Healthpeak Properties
64
Buy
VS
NLY
Annaly Capital Management
67
Buy
| Metric | DOC | NLY |
| AI Score |
64
|
67
|
| Price |
$20.50
|
$23.14
|
| P/E Ratio |
58.60×
|
5.77×
|
| ROE |
1.0%
|
12.6%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
2.5%
|
99.3%
|
| Debt / Equity |
1.32×
|
7.38×
|
| Dividend Yield |
5.9%
|
12.3%
|
| RSI (14) |
31.1
|
55.0
|
| Beta |
0.991
|
1.239
|
| Expected Upside |
+1.6%
|
+0.4%
|
AI Committee View
Current Innellis committee reasoning for DOC versus NLY.
NLY leads by 3 points.
NLY scores 67/100 (Buy) versus DOC at 64/100 (Buy).
DOC Committee View
50% agreement
4 analysts
The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.
Bull Case
- 4 consecutive earnings beats -- consistent execution — Growth
- Weekly trend (sideways) confirms the daily trend -- multi-timeframe agreement — Technical
- VIX regime is low -- calm backdrop supports risk-taking — Macro
Bear Case
- Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth
- MACD histogram negative -- bearish momentum — Technical
- Price trading below the lower Bollinger Band -- stretched to the downside — Technical
NLY Committee View
67% agreement
6 analysts
The primary driver is revenue growing 50.9% yoy -- genuine top-line momentum. The main limiting factor is macd histogram negative -- bearish momentum. The committee is constructive but not yet at full conviction.
Bull Case
- P/E of 5.8 is inexpensive for the broad market — Value
- Price-to-book of 1.0x is a discount to asset value — Value
- ROE of 18.4% shows genuine earnings power backing the valuation — Value
Bear Case
- Debt-to-equity of 7.22 adds balance-sheet risk to the value case — Value
- MACD histogram negative -- bearish momentum — Technical
- High leverage (debt-to-equity 7.22) amplifies downside in a stress scenario — Risk